These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2. Fraser AD, Worth D. Forensic Sci Int; 2003 Apr 23; 133(1-2):26-31. PubMed ID: 12742686 [Abstract] [Full Text] [Related]
3. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study. Fraser AD, Worth D. Forensic Sci Int; 2003 Nov 26; 137(2-3):196-202. PubMed ID: 14609657 [Abstract] [Full Text] [Related]
4. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid. Manno JE, Manno BR, Kemp PM, Alford DD, Abukhalaf IK, McWilliams ME, Hagaman FN, Fitzgerald MJ. J Anal Toxicol; 2001 Oct 26; 25(7):538-49. PubMed ID: 11599597 [Abstract] [Full Text] [Related]
5. Elimination of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol when normalized to urinary creatinine. Beardsley GD, Christensen JM. Res Commun Mol Pathol Pharmacol; 2001 Oct 26; 120-121(1-6):67-78. PubMed ID: 21469505 [Abstract] [Full Text] [Related]
6. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. Huestis MA, Mitchell JM, Cone EJ. J Anal Toxicol; 1996 Oct 26; 20(6):441-52. PubMed ID: 8889681 [Abstract] [Full Text] [Related]
8. Rapid quantification of urinary 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid using fast gas chromatography-mass spectrometry. Jamerson MH, Welton RM, Morris-Kukoski CL, Klette KL. J Anal Toxicol; 2005 Oct 26; 29(7):664-8. PubMed ID: 16419397 [Abstract] [Full Text] [Related]
9. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV. Fraser AD, Worth D. Forensic Sci Int; 2004 Jul 16; 143(2-3):147-52. PubMed ID: 15240035 [Abstract] [Full Text] [Related]
10. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study. ElSohly MA, deWit H, Wachtel SR, Feng S, Murphy TP. J Anal Toxicol; 2001 Oct 16; 25(7):565-71. PubMed ID: 11599601 [Abstract] [Full Text] [Related]
13. Urine pH, container composition, and exposure time influence adsorptive loss of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid. Jamerson MH, McCue JJ, Klette KL. J Anal Toxicol; 2005 Oct 16; 29(7):627-31. PubMed ID: 16419391 [Abstract] [Full Text] [Related]
14. Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. Kelly P, Jones RT. J Anal Toxicol; 1992 Oct 16; 16(4):228-35. PubMed ID: 1323733 [Abstract] [Full Text] [Related]
15. Novel automated extraction method for quantitative analysis of urinary 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid (THC-COOH). Fu S, Lewis J. J Anal Toxicol; 2008 May 16; 32(4):292-7. PubMed ID: 18430296 [Abstract] [Full Text] [Related]
16. [Routine detection of the THC metabolite 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in forensic practice]. Hanke M, Megges G. Z Rechtsmed; 1983 May 16; 90(2):105-8. PubMed ID: 6312709 [Abstract] [Full Text] [Related]
17. [Detection of the metabolite of delta-9-tetrahydrocannabinol in urine by means of GC/MS and interpretation of analytical findings]. Balíková M, Maresová V. Soud Lek; 1996 Dec 16; 41(4):36-40. PubMed ID: 16841441 [Abstract] [Full Text] [Related]
20. Confirmation of cannabis abuse by the determination of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine with high-performance liquid chromatography and electrochemical detection. Bourquin D, Brenneisen R. J Chromatogr; 1987 Feb 20; 414(1):187-91. PubMed ID: 3033002 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]